Candel Therapeutics
CADL
CADL
23 hedge funds and large institutions have $20.6M invested in Candel Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $34M → $20.6M (-$13.4M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.41M | |
| 2 | +$187K | |
| 3 | +$5.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.82K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.34K |
Top Sellers
| 1 | -$3.48M | |
| 2 | -$208K | |
| 3 | -$55K | |
| 4 |
BlackRock
New York
|
-$9.56K |
| 5 |
JPMorgan Chase & Co
New York
|
-$6.86K |